Genitourinary Cancers Special Issue | CURE

September 30, 2016

Like his signature backflip, Olympic figure skater Scott Hamilton’s vision for supporting patients with cancer is bold and unique.

September 29, 2016

Does PSA-based prostate cancer screening lead to less deaths from the disease? CURE explores both sides of the debate.

September 29, 2016

Not all patients with prostate cancer benefit from the same therapies. Here's a look at some of the hormone therapy options available.

September 28, 2016

Treating bladder cancer with a cystectomy may bring about some complicated side effects. Here are some resources to help.

September 28, 2016

CURE gathered some need-to-know facts about bladder cancer, the sixth most common cancer.

September 27, 2016

With a variety of treatment options for prostate cancer also comes a variety of side effects. Here is a list of potential side effects to discuss with your doctor when deciding on a treatment plan.

September 27, 2016

For decades, research into bladder cancer treatments was stagnant, but now science has moved into a period rife with new approaches — immunotherapy chief among them.

September 24, 2016

Cisplatin therapy can cause hearing loss for men with testicular cancer, but preventive measures are emerging.

September 23, 2016

The treatment landscape for advanced kidney cancer has changed dramatically over the past few years, with several targeted drugs and an immunotherapy approved by the FDA.

September 23, 2016

In discussions of cancer these days, there may be no word mentioned more often than “immunotherapy,” and bladder cancer provides us with an excellent example of why this strategy is so important, writes our chairman and CEO, Mike Hennessy, Sr.

September 23, 2016

Ten years ago, patients with advanced RCC had very few treatment options, yet today, there are multiple therapeutic strategies and more in the pipeline for this not-very-common tumor type, writes our editor-in-chief, Debu Tripathy.

September 22, 2016

After the bladder is surgically removed and the urinary system diverted, most can return to their usual activities.

September 20, 2016

After a host of recent advances in the treatment of prostate cancer, the forward push continues as immunotherapy and combinations of older agents are tested in patients.